An Adjustable Implant for the Nasal Valve: 3-Year Experience

2008 ◽  
Vol 139 (2_suppl) ◽  
pp. P72-P72
Author(s):  
Charles G Hurbis
Keyword(s):  
Nasal Valve ◽  
Valve Dysfunction ◽  
Nasal Airways ◽  
Quality Of Life Scale ◽  
Life Scale ◽  
Nasal Implant ◽  
Scale Data ◽  
Implantation Success

Objective 1) Measure the effectiveness of the Monarch implant in correcting nasal valve dysfunction. 2) Determine the longevity of effectiveness. Methods This study consists of a prospective, cumulative, three-year experience with the Monarch adjustable nasal implant for correcting nasal valve dysfunction in a total of 46 patients. Implantation success was determined by the use of acoustic rhinomanometry and a subjective NOSE-type quality of life scale. Data was subjected to the student-t test. Results In the series of 46 patients spanning 36 months there is a mean 150% improvement in the internal nasal valve areas at 3 years as measured by acoustic rhinomanometry (p<.0001). Using a NOSE-type questionnaire, patients also noted significant improvements in daytime (p<.0004) and nighttime (p<.0002) nasal airways, a decrease in apnea (p<.01) and snoring (p<.05), and a decrease in the propensity for daytime oral breathing (p<.0002). Conclusions The Monarch Implant provides a simple, consistent, adjustable and apparently long-term correction of the nasal airway in patients suffering from nasal valvular dysfunction.

Welfare of cats 5–29 months after perineal urethrostomy: 74 cases (2015–2017)

2019 ◽  
Vol 22 (6) ◽  
pp. 582-588 ◽  
Author(s):  
Margaret R Slater ◽  
Sharon Pailler ◽  
J’mai M Gayle ◽  
Illoneete Cohen ◽  
Erin L Galloway ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Case Series ◽  
Life Outcomes ◽  
Retrospective Case ◽  
Quality Of Life Scale ◽  
Life Scale ◽  
Potential Factors ◽  
American Society

Objectives The objective of this study was to evaluate the long-term quality of life in cats following perineal urethrostomy. Methods This study comprised a retrospective case series of 74 cats with urinary obstructions that received perineal urethrostomies at the American Society for the Prevention of Cruelty to Animals (ASPCA) Animal Hospital between September 2015 and July 2017. Medical records were reviewed for information on the number of obstructions prior to surgery, urinary tract problems at the time of surgery and other potential factors influencing long-term welfare. Owners were surveyed by telephone and text 5–29 months after their cat’s surgery. Responses were compiled and analyzed to determine owner perception of welfare postsurgery, and to identify patterns in medical history and welfare outcomes. Results In total, 105 cat owners were eligible for the survey; 74 responded. Altogether, 100% of responding individuals reported at least the same quality of life postsurgery compared with the cat’s quality of life before demonstrating urinary problems (48% reported better). On a quality-of-life scale of 1–10 (10 = excellent), 100% of responding cat owners reported at least 7; 75% reported 10. Conclusions and relevance Quality-of-life outcomes for cats 5–29 months after receiving perineal urethrostomy surgery were reported to be very good. Given this finding, and that perineal urethrostomy surgery should mitigate future blockages, we suggest considering perineal urethrostomy surgery as a standard tool to manage urinary obstructions in cats. The needs of the specific client and patient, including risks, costs and welfare of the cats, should drive the options for management of urinary obstructions in male cats.

Analisis of quality of life long-term hospitalized schizophrenic patients

2011 ◽  
Vol 26 (S2) ◽  
pp. 1513-1513 ◽  
Author(s):  
G. Tasic ◽  
S. Anakiev ◽  
D. Milosevic ◽  
M. Cvetanovic
Keyword(s):  
Quality Of Life ◽  
Rating Scale ◽  
Length Of Hospital Stay ◽  
Hospital Treatment ◽  
Quality Of Life Scale ◽  
Life Scale ◽  
Icd 10 ◽  
Schizophrenic Patients

IntroductionLong term hospitalization are often caused by social reasons wich significantly affects the quality of the patients.AimComparing the quality of long-term hospitalized schizophrenic patients in relation to sex.MethodWe have used following rating scale: a brief psychiatric assessment scale BPRS, QLS Quality of life scale, “Lancashir” profile quality of life scale LQOLP, a short questionnaire for the “needs assessment Cambersels” scale CANSAS. Analysis included 80 inpatients, 40 male and 40 female, with Schizophrenia according to ICD 10 criteria. All patients were hospitalized according to ICD 10 criteria. All patients were hospitalized in a Special Hospital For Psychiatric Illness G. Toponica more than two years.ResultsSignificant differences in quality of life between male and female patients about what is discussed in further study.ConclusionsResearch has shown that long-term hospitalizing has adverse effects on quality of life of schizophrenic patients of both sexes. His essential that the length of hospital stay should be reduced to the period reduced to the period for reduction of symptoms and provide the patient a stable life in the community after hospital treatment.

Study of premenstrual syndrome and premenstrual dysphorik disorder in Azerbaijan

2011 ◽  
Vol 26 (S2) ◽  
pp. 1667-1667
Author(s):  
S. Katibli
Keyword(s):  
Quality Of Life ◽  
Social Life ◽  
Health Program ◽  
Long Term Outcomes ◽  
Premenstrual Symptoms ◽  
Quality Of Life Indicators ◽  
Quality Of Life Scale ◽  
Life Scale

ObjectivesThe study is aimed to investigate clinical and social aspects of premenstrual disorders in Azerbaijan.Methods180 women at the age 20–49 from general population have been included in the research. The study used the Premenstrual Symptoms Screening Tool to assess severity of premenstrual symptoms. The women's quality of life was evaluated with QoLS (Quality of life Scale).ResultsThe most prevalent complaints included sleep disorders, fatigue, irritability and depressed mood. These symptoms affected work efficiency or productivity, relationships with co-workers, relationships with family members, social life activities, and home responsibilities. At the same time short-term presentation of these symptoms had limited impact on quality of life indicators attributed to long-term outcomes.ConclusionsThe activities on increasing awareness on premenstrual disorders are recommended as an important component of reproductive health program.

Efficacy and Complications of Microsurgical Neurovascular Decompression in 55 Patients With Hemifacial Spasm

2020 ◽  
pp. 019459982096916
Author(s):  
Chloé Compagnon ◽  
Marc Labrousse ◽  
Esteban Brenet ◽  
André Chays ◽  
Arnaud Bazin ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Hemifacial Spasm ◽  
Microvascular Decompression ◽  
Unilateral Deafness ◽  
Quality Of Life Scale ◽  
Life Scale ◽  
Life Improvement ◽  
Neurovascular Decompression

Objective To analyze the efficacy and complications of microvascular decompression for hemifacial spasm. Study Design Retrospective study. Setting Regional hospital. Methods Fifty-five patients with hemifacial spasm were treated by microvascular decompression. All patients with hemifacial spasm who underwent retrosigmoid microvascular decompression from May 2004 to January 2017 were included. Patients with no conflict on preoperative magnetic resonance imaging or with an alternate diagnosis were excluded. Results The overall cure rate was 83.64%, with an average follow-up of 7.4 years. A left-sided hemifacial spasm was a healing-promoting factor ( P = .01). The median healing was 0.03 months, and the mean was 6 months. The efficacy remained high in the medium term (88% at 3 years), long term (90.24% at 5 years), and very long term (90.48% at 8 years). The recurrence rate was 9.8%. Favorable criteria included a right-sided spasm ( P = .01) and an average age of 62 years ( P = .03). The specific complications were permanent facial palsy (3.63%), unilateral deafness (5.45%), and hearing loss (3.63%). No death was reported. Regarding the quality of life of the patients, 94.7% had a modified HFS-8 postoperative score of 0 (Hemifacial Spasm 8 Quality of Life Scale). Conclusion Microvascular decompression for hemifacial spasm is an effective and lasting technique. Its low rate of complications and the considerable quality-of-life improvement should lead surgeons to propose it to patients as soon as botulinum toxin injections become ineffective or poorly tolerated.

The Mild and Rapidly Improving Stroke Study (MaRISS): Rationale and design

2019 ◽  
Vol 14 (9) ◽  
pp. 983-986
Author(s):  
Jose G Romano ◽  
Hannah Gardener ◽  
Iszet Campo-Bustillo ◽  
Yosef Khan ◽  
Nikesha Riley ◽  
...  
Keyword(s):  
Hemorrhagic Transformation ◽  
Safety Outcome ◽  
Stroke Impact Scale ◽  
Stroke Study ◽  
Impact Scale ◽  
Quality Of Life Scale ◽  
Life Scale ◽  
Index Stroke

Rationale Although mild and rapidly improving stroke symptoms are the most common first stroke presentation, this group has been understudied in acute stroke trials. Observational and retrospective studies suggest residual disability in one third of patients. Aims To elucidate long-term outcomes of patients with mild and rapidly improving stroke, evaluate the predictors of outcome, and examine the association with alteplase treatment. Sample size The initial estimate of 2650 participants to detect a 9% difference in non-disabled 90-day outcomes between alteplase-treated and untreated participants was revised to 2000 after a pre-planned re-estimation based on actual treatment rates. Methods and design Prospective observational study of patients with mild ischemic stroke (NIHSS ≤ 5) or rapidly improving stroke symptoms evaluated within 4.5 h from onset. Outcomes The primary outcome is the proportion of patients with modified Rankin Scale (mRS) ≥ 2 at 90 days; the primary safety outcome is symptomatic hemorrhagic transformation within 36 h among those treated with alteplase. Secondary outcomes include the 90-day Barthel Index, Stroke Impact Scale 16, European Quality of Life scale, mRS at 30 days, and 30- and 90-day mortality. Discussion MaRISS will define outcomes and their predictors and clarify the effects of alteplase in patients with mild and rapidly improving stroke symptoms, providing clinicians with important information to manage this population.

Stroke Specific Quality of Life Scale--French Version

2018 ◽  
Author(s):  
Nicolas Legris ◽  
Hervé Devilliers ◽  
Anaïs Daumas ◽  
Didier Carnet ◽  
Jean-Pierre Charpy ◽  
...  
Keyword(s):  
Quality Of Life ◽  
French Version ◽  
Quality Of Life Scale ◽  
Life Scale

Acne Quality of Life Scale

1998 ◽  
Author(s):  
Madhulika A. Gupta ◽  
Andrew M. Johnson ◽  
Aditya K. Gupta
Keyword(s):  
Quality Of Life ◽  
Quality Of Life Scale ◽  
Life Scale
Sign in / Sign up

Export Citation Format

Share Document